AstraZeneca announced that its drug Lynparza (olaparib) has been approved for use in Scotland. The approval by the Scottish ...

Several studies have been completed looking at the effect of BPO in women at high risk of developing ovarian cancer because of family history or because of being mutation carriers of either BRCA1 ...

Medical experts through out di world dey wonder say cancer cases dey increase in younger pipo wey di disease no dey dia ...

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...

Cancer has been regarded traditionally as a disease of aging. Routine screening for cancer is advised for individuals aged 40 ...

Patients with HRR-deficient metastatic castration-resistant prostate cancer experienced a 14-month gain in OS and a 38% lower ...

This National Cancer Prevention Month, Epic Care encourages you to take proactive steps to reduce your cancer risk. Speak ...

Although Nor Haryati has finished her treatment, doctors were loathe to say she was cancer-free due to the genetic mutation.

The Italian supermodel, 40, who was diagnosed with ovarian cancer last year, wore four stunning sequinned ensembles as she ...

This National Cancer Prevention Month, Epic Care encourages you to take proactive steps to reduce your cancer risk. Speak ...

With delays in biomarker testing and treatment for metastatic castration-resistant prostate cancer, continued education is ...